Anti-inflammatory properties of Lipidosterolic extract of Serenoa repens (Permixon®) in a mouse model of prostate hyperplasia
Author:
Affiliation:
1. Inserm U1151; Université Paris Descartes; Paris France
2. Cellule d'Opportunités; Institut de Recherche Pierre Fabre; Toulouse France
3. Institute for European Expertise in Physiology; Paris France
Funder
Institut de Recherche Pierre Fabre
Institut National de la Santé et de la Recherche Médicale
Institute for European Expertise in Physiology
Publisher
Wiley
Subject
Urology,Oncology
Reference51 articles.
1. Serenoa repens for benign prostatic hyperplasia;Tacklind;Cochrane Database Syst Rev,2012
2. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH);Gandaglia;BJU Int,2013
3. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?;Kramer;Eur Urol,2007
4. Prostate cancer as a model for tumour immunotherapy;Drake;Nat Rev Immunol,2010
5. De La TA. Inflammation in benign prostatic hyperplasia: A 282 patients' immunohistochemical analysis;Robert;Prostate,2009
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cell Plasticity in a Mouse Model of Benign Prostate Hyperplasia Drives Amplification of Androgen-Independent Epithelial Cell Populations Sensitive to Antioxidant Therapy;The American Journal of Pathology;2024-01
2. Evodiamine impairs HIF1A histone lactylation to inhibit Sema3A-mediated angiogenesis and PD-L1 by inducing ferroptosis in prostate cancer;European Journal of Pharmacology;2023-10
3. CXCL6: A potential therapeutic target for inflammation and cancer;Clinical and Experimental Medicine;2023-08-23
4. Variability of Commercial Saw Palmetto–Based Supplements for the Management of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms;JU Open Plus;2023-08
5. Efficacy and Safety of a Natural Supplement Containing Serenoa Repens, Solanum Lycopersicum, Lycopene, and Bromelain in Reducing Symptoms of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Prospective Cohort Study in 250 Patients;Uro;2023-07-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3